Scholar Rock Holding (SRRK) EBT (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.53% |
| Dec 31, 2025 | 11.01% |
| Sep 30, 2025 | 7.05% |
| Jun 30, 2025 | -47.17% |
| Mar 31, 2025 | -12.40% |
| Dec 31, 2024 | -3.11% |
| Sep 30, 2024 | -10.17% |
| Jun 30, 2024 | -2.92% |
| Mar 31, 2024 | -18.32% |
| Dec 31, 2023 | -9.98% |
| Sep 30, 2023 | -11.74% |
| Jun 30, 2023 | 3.52% |
| Mar 31, 2023 | -0.20% |
| Dec 31, 2022 | 7.83% |
| Sep 30, 2022 | -1.66% |
| Jun 30, 2022 | -522.34% |
| Mar 31, 2022 | 80.40% |
| Dec 31, 2021 | 4.62% |
| Sep 30, 2021 | -22.48% |
| Jun 30, 2021 | -11.27% |
| Mar 31, 2021 | -4.23% |
| Dec 31, 2020 | -10.53% |
| Sep 30, 2020 | -21.35% |
| Jun 30, 2020 | -9.99% |
| Mar 31, 2020 | -43.31% |
| Dec 31, 2019 | 27.82% |
| Sep 30, 2019 | -27.79% |
| Jun 30, 2019 | -14.38% |
| Mar 31, 2019 | 24.79% |
| Dec 31, 2018 | -38.51% |
| Sep 30, 2018 | 24.52% |
| Jun 30, 2018 | -65.08% |
| Mar 31, 2018 | -6.60% |
| Dec 31, 2017 | -42.34% |
| Sep 30, 2017 | -0.92% |